Episode 4: Accelerated Regulatory Pathways and Patient Access

In this episode, Parexel’s Mwango Kashoki, a former FDA regulator, and Richard Macaulay, who specializes in market access challenges, join Alberto Grignolo to discuss expedited regulatory pathways and how they can impact payer evaluation. In particular, the discussion focuses on how the gap between regulatory approval and reimbursement can affect patient access to new therapies and how new models are being developed to address this dilemma.